Tag: licensing
-
Company Licenses Ultrasound Atherosclerosis Therapy
International Cardio Corporation (ICC) in Excelsior, Minnesota has licensed technology developed at University of Minnesota to treat atherosclerosis with ultrasound. The ultrasound treatment is considered less invasive and potentially safer for the patient than current therapies, such as stents and balloon angioplasty. Atherosclerosis is the name of the process in which deposits of fatty substances,…
-
FDA Approves Improved Laser Eye Surgery Technology
The U.S. Food and Drug Administration approved an enhanced technology for refractive (laser) eye surgery, based on research conducted at University of Rochester in New York. The Rochester Nomogram, as the technology is called, is licensed to Technolas Perfect Vision, a cataract and refractive laser company formed through a joint venture of lens manufacturer Bausch…
-
U.K. Company Licenses Harvard Graphene DNA Technology
Oxford Nanopore Technologies Ltd. in Oxford, U.K. said today it signed a licensing agreement with Harvard University to commercialize graphene technology from Harvard’s labs for DNA sequencing. The company already has a deal with Harvard’s technology transfer office to develop basic sensing methods through solid-state nanopores. Graphene is a robust, single-atom thick lattice of carbon…
-
Universities License Regenerative Membrane Technology
The technology transfer offices at Hebrew University of Jerusalem and Hadassah University Medical Center in Israel, say they have licensed technology for regenerative membrane implants developed at their institutions. RegeneCure, the licensee — also in Jerusalem — will further develop and commercialize the technology for bone tissue engineering in trauma, spine, and reconstructive cranial and…
-
Tufts University Gets Patent for Kidney Disease Treatment
Researchers at Tufts University’s veterinary school in Grafton, Massachusetts have received a U.S. patent for an antibody-based treatment for hemolytic uremic syndrome (HUS), a potentially fatal outcome of E. coli poisoning and a leading cause of kidney failure in children. The Tufts technology covered by the patent, developed by microbiology professor Saul Tzipori, uses human…
-
Biotech Licenses Technology for Colorectal Cancer Blood Test
Epigenomics AG in Berlin, Germany says it has an agreement for QIAGEN NV in the Netherlands to further develop Epigenomics’s research into a blood test for colorectal cancer. QIAGEN also has an option under the agreement to take the blood test to market. The technology is based on Epigenomics’s research into genomics and DNA indicators…
-
Venture Fund to Finance Univ. Tech. Start Ups
Osage University Partners in Bala Cynwyd, Pennsylvania says it completed fund raising for its first venture capital fund financing new enterprises that license technology developed in university labs. The company says the fund, called Osage University Partners 1, achieved its goal of raising $100 million. Osage University Partners was founded in 2009 by venture professionals…
-
Michigan Start Up Company Licenses Biodiesel Technology
NextCAT Inc. in Detroit, Michigan says it has licensed biofuel catalyst technology developed at the National Biofuels Energy Lab at Wayne State University, also in Detroit. The company says the technology can help restart the biodiesel industry that has been mostly idle in the United States since 2008, when rising feedstock prices made the production…
-
Chemistry Prof. Commercializes Hydrogen Fuel Cell Technology
A chemistry professor at Michigan State University in East Lansing developed a process for making inexpensive hydrogen fuel cells to generate cheap electrical power, and helped start a business to bring that technology to market. A company making portable device chargers has now licensed the technology and unveiled its product this week. James Dye has…
-
Medical Device Maker Licenses Spinal Surgery Technology
Integra LifeSciences in Plainsboro, New Jersey says it has agreed to license and further develop technology made by Stout Medical Group in Perkasie, Pennsylvania to improve spinal surgery. Integra estimates the market value for these kind of devices to exceed $750 million. Under the agreement, Integra will develop a device that surgeons can implant into…